Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-367-10, UPC 3 42291 36710 4
Published August 17, 2022 · Recall initiated: July 20, 2022
Summary
FDA records drug Class III recall D-1329-2022, published August 17, 2022 and initiated July 20, 2022. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 8328 bottles; Lot: Lot #: 42581 Exp. 12/2024; 42484 Exp. 11/2024; 41204 Exp. 05/2024; 38723 Exp. 02/2023; 37623 Exp. 10/2022. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error on Declared Strength
What to do
Voluntary: Firm initiated · Letter
Get an email if LAMOTRIGINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LAMOTRIGINE
- Manufacturer
- AVKARE Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0342291368606
- Lot
- Lot #: 42581 Exp. 12/2024; 42484 Exp. 11/2024; 41204 Exp. 05/2024; 38723 Exp. 02/2023; 37623 Exp. 10/2022
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADifluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by CiplaAugust 17, 2022
- FDAPrednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd.,August 17, 2022
- FDALamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDCJune 10, 2020
- FDALamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd.February 19, 2020
- FDALamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For:September 26, 2018
- FDALamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by: Unichem LaboratoriesOctober 5, 2016
Questions about this recall
Was Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-367-10, UPC 3 42291 36710 4 recalled?
Yes. FDA published recall D-1329-2022 on August 17, 2022. Reported hazard: Labeling: Label Error on Declared Strength
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LAMOTRIGINE. UPC: 0342291368606.